Primaquine for plasmodium vivax malaria treatment – authors' reply
Үндсэн зохиолчид: | Price, RN, Taylor, WRJ, Thriemer, K, White, NJ, Day, NP |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Elsevier
2020
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
-н: Setyadi, A, зэрэг
Хэвлэсэн: (2019) -
Higher-dose primaquine to prevent relapse of Plasmodium vivax malaria
-н: Watson, JA, зэрэг
Хэвлэсэн: (2022) -
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
-н: Taylor, WRJ, зэрэг
Хэвлэсэн: (2023) -
The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
-н: Thriemer, K, зэрэг
Хэвлэсэн: (2020) -
Treatment of primaquine-resistant Plasmodium vivax malaria.
-н: Luzzi, G, зэрэг
Хэвлэсэн: (1992)